Free Trial

Aspira Women's Health (AWH) Competitors

Aspira Women's Health logo
$0.18 -0.02 (-11.62%)
Closing price 03/11/2025 04:00 PM Eastern
Extended Trading
$0.16 -0.01 (-8.00%)
As of 08:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AWH vs. IXHL, CRVO, CTXR, IMNN, BCTX, MTVA, GELS, TRIB, MBRX, and PMCB

Should you be buying Aspira Women's Health stock or one of its competitors? The main competitors of Aspira Women's Health include Incannex Healthcare (IXHL), CervoMed (CRVO), Citius Pharmaceuticals (CTXR), Imunon (IMNN), BriaCell Therapeutics (BCTX), MetaVia (MTVA), Gelteq (GELS), Trinity Biotech (TRIB), Moleculin Biotech (MBRX), and PharmaCyte Biotech (PMCB). These companies are all part of the "pharmaceutical products" industry.

Aspira Women's Health vs.

Incannex Healthcare (NASDAQ:IXHL) and Aspira Women's Health (NASDAQ:AWH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, community ranking, institutional ownership and dividends.

Incannex Healthcare has a beta of 7.49, suggesting that its stock price is 649% more volatile than the S&P 500. Comparatively, Aspira Women's Health has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500.

Aspira Women's Health received 14 more outperform votes than Incannex Healthcare when rated by MarketBeat users.

CompanyUnderperformOutperform
Incannex HealthcareN/AN/A
Aspira Women's HealthOutperform Votes
14
17.72%
Underperform Votes
65
82.28%

0.4% of Incannex Healthcare shares are owned by institutional investors. Comparatively, 12.2% of Aspira Women's Health shares are owned by institutional investors. 26.5% of Incannex Healthcare shares are owned by company insiders. Comparatively, 4.3% of Aspira Women's Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Aspira Women's Health has a consensus price target of $4.40, indicating a potential upside of 2,414.29%. Given Aspira Women's Health's stronger consensus rating and higher possible upside, analysts clearly believe Aspira Women's Health is more favorable than Incannex Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Incannex Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aspira Women's Health
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Incannex Healthcare has a net margin of 0.00% compared to Aspira Women's Health's net margin of -165.07%. Aspira Women's Health's return on equity of 0.00% beat Incannex Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Incannex HealthcareN/A -289.30% -154.96%
Aspira Women's Health -165.07%N/A -267.23%

Aspira Women's Health has higher revenue and earnings than Incannex Healthcare. Incannex Healthcare is trading at a lower price-to-earnings ratio than Aspira Women's Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Incannex Healthcare$98K133.22-$18.46M-$1.39-0.53
Aspira Women's Health$8.96M0.35-$16.69M-$1.20-0.15

In the previous week, Incannex Healthcare had 3 more articles in the media than Aspira Women's Health. MarketBeat recorded 4 mentions for Incannex Healthcare and 1 mentions for Aspira Women's Health. Aspira Women's Health's average media sentiment score of 0.94 beat Incannex Healthcare's score of 0.77 indicating that Aspira Women's Health is being referred to more favorably in the news media.

Company Overall Sentiment
Incannex Healthcare Positive
Aspira Women's Health Positive

Summary

Aspira Women's Health beats Incannex Healthcare on 11 of the 17 factors compared between the two stocks.

Remove Ads
Get Aspira Women's Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for AWH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AWH vs. The Competition

MetricAspira Women's HealthDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$3.09M$2.56B$5.67B$8.00B
Dividend YieldN/A0.70%4.89%4.03%
P/E Ratio-0.155.7423.8618.90
Price / Sales0.3551.57382.37118.46
Price / CashN/A15.7538.0534.62
Price / Book-0.763.156.844.18
Net Income-$16.69M-$65.73M$3.19B$246.59M
7 Day Performance2.04%-0.67%-2.26%-3.09%
1 Month Performance-43.73%-8.97%-7.20%-8.97%
1 Year Performance-95.22%-22.51%8.72%0.74%

Aspira Women's Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AWH
Aspira Women's Health
1.0656 of 5 stars
$0.18
-11.6%
$4.40
+2,414.3%
-95.3%$3.09M$8.96M-0.15110Positive News
Gap Down
High Trading Volume
IXHL
Incannex Healthcare
0.9704 of 5 stars
$0.78
-10.3%
N/A-83.6%$13.93M$98,000.00-0.563Gap Down
CRVO
CervoMed
2.7381 of 5 stars
$2.22
+0.5%
$37.43
+1,586.0%
-86.7%$13.70M$7.14M0.004Analyst Forecast
Analyst Revision
News Coverage
Gap Down
High Trading Volume
CTXR
Citius Pharmaceuticals
2.9778 of 5 stars
$1.58
-11.7%
$54.50
+3,349.4%
-91.1%$13.58MN/A0.0020Positive News
IMNN
Imunon
2.756 of 5 stars
$0.89
-1.7%
$20.50
+2,203.4%
-9.0%$13.01M$500,000.00-0.4730Gap Up
BCTX
BriaCell Therapeutics
2.2059 of 5 stars
$3.45
-2.3%
$32.00
+827.5%
-91.9%$12.80MN/A-0.268Upcoming Earnings
Positive News
MTVA
MetaVia
1.3887 of 5 stars
$1.48
-4.5%
$12.00
+710.8%
N/A$12.75MN/A0.0010Positive News
GELS
Gelteq
N/A$1.35
+5.5%
N/AN/A$12.74MN/A0.00N/A
TRIB
Trinity Biotech
1.2869 of 5 stars
$0.70
+0.7%
N/A-66.1%$12.57M$59.13M-0.31480Gap Up
MBRX
Moleculin Biotech
2.2017 of 5 stars
$1.15
+2.7%
$18.67
+1,523.2%
-87.4%$12.48MN/A0.0020Gap Down
PMCB
PharmaCyte Biotech
0.9722 of 5 stars
$1.78
flat
N/A-12.4%$12.40MN/A3.364Upcoming Earnings
Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:AWH) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners